 |
Page History
...
| Data Element | Description | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCI _ ID | The
| ||||||||||
| Lead _ Org _ ID | The
information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. | ||||||||||
| Title | The
information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. | ||||||||||
| Lead Org Organization PO ID | Identifier The unique ID assigned to the lead organization by the CTRP. For more information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. | ||||||||||
| Lead _ Organization | The
| ||||||||||
| NCT _ ID | The
| ||||||||||
| CTEP ID | The
| ||||||||||
| DCP ID | The
| ||||||||||
| Funding Mechanism | Unique, three-character code for the funding mechanism of a grant on a trial. NIH assigns these codes to areas of extramural research activity. For more information, refer to A
| ||||||||||
| NCI Division/Program | NCI organizational unit that provides funding for the trial, as The NCI division or program identified in an IND, IDE, or grant record, as the
information, refer | ||||||||||
| Institution Code | The NIH institution associated with the trial, as identified in an IND, IDE, or grant record. For information, refer to NIH Institution Code Values, NIH Grant Institute Code Values, Abstracting INDs and IDEs, or Abstracting Funding. | ||||||||||
| IND/IDE Grantor | The
For information, refer to Abstracting INDs and IDEs. | ||||||||||
| IND/IDE Holder Type | The
For information, refer to Abstracting INDs and IDEs. | ||||||||||
| IND/IDE Number | The
| ||||||||||
| IND/IDE Types | Value indicating whether the trial involves an Investigational New Drug Application (IND) or Investigational Device Exemption (IDE). For more A value indicating
| ||||||||||
| Section _ 801 _ Indicator | Value indicating whether the FDA-regulated interventional trial is an applicable trial as defined in US Public Law 110-85, Title VIII, Section 801. For more A value indicating
| ||||||||||
| Principal _ Investigator | The
| ||||||||||
| Sponsor _ Org | The
| ||||||||||
| Responsible _ Party | The
| ||||||||||
| Summary _ 4 _ Funding _ Sponsor | The
information, refer to Abstracting Sponsors and Responsible Parties. | ||||||||||
| Trial _ Status | The
| ||||||||||
| Trial _ Status _ Date | The
| ||||||||||
| Trial _ Start _ Date | The
| ||||||||||
| Primary Completion Date | The
| ||||||||||
| Primary Completion Date Type | A
| ||||||||||
| Submitting _ Org _ Name | Name The name of the organization that submitted the trial. | ||||||||||
| Current Processing Status | The
| ||||||||||
| Study _ Category | The
| ||||||||||
| Submission Number | A
information, refer to Processing Trial History Information. | ||||||||||
| Trial Submission Type | Value indicating whether the trial record is an original submission or an amendment. For more A value indicating
| ||||||||||
| Trial Summary Report Sent Date | Date The date on which the system sent the Trial Summary Report (TSR) to the principal investigator or trial submitter. For more information, refer to Processing Trial Milestones. |
...
| hidden | true |
|---|
...
| . |
